<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li ZZ</submitter><funding>Key Project of Innovation Research 2035 Pilot Plan of Southwest University</funding><funding>National Natural Science Foundation of China</funding><funding>the Key Project of Tianjin Municipal Natural Science Foundation of China</funding><funding>Chongqing Graduate Research Innovation Project</funding><pagination>11836</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12733231</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>26(24)</volume><pubmed_abstract>The emergence of bacterial infections as a critical public health challenge underscores the urgent need for innovative therapeutic strategies. We designed and synthesized a series of novel heteroaryl bishydrozono nitroimidazoles and their analogs by strategically hybridizing multiple molecular components through diverse linkers. Among the newly synthesized compounds, compound &lt;b>4&lt;/b> displayed a broad-spectrum antibacterial profile with low cytotoxicity and hemolysis. It could inhibit the proliferation of methicillin-resistant &lt;i>Staphylococcus aureus&lt;/i> and reduce its metabolic activity with low bacterial resistance. Further investigations revealed that the highly active compound &lt;b>4&lt;/b> could not only disrupt cell membrane integrity and induce excessive reactive oxygen species within </pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Heteroaryl Bishydrazono Nitroimidazoles: A Unique Structural Skeleton with Potent Multitargeting Antibacterial Activity.</pubmed_title><pmcid>PMC12733231</pmcid><funding_grant_id>24ZXZSSS00020</funding_grant_id><funding_grant_id>CYS18114</funding_grant_id><funding_grant_id>SWU-XDZD22007</funding_grant_id><funding_grant_id>82473771</funding_grant_id><pubmed_authors>Liu YJ</pubmed_authors><pubmed_authors>Zhou CH</pubmed_authors><pubmed_authors>Li ZZ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Heteroaryl Bishydrazono Nitroimidazoles: A Unique Structural Skeleton with Potent Multitargeting Antibacterial Activity.</name><description>The emergence of bacterial infections as a critical public health challenge underscores the urgent need for innovative therapeutic strategies. We designed and synthesized a series of novel heteroaryl bishydrozono nitroimidazoles and their analogs by strategically hybridizing multiple molecular components through diverse linkers. Among the newly synthesized compounds, compound &lt;b>4&lt;/b> displayed a broad-spectrum antibacterial profile with low cytotoxicity and hemolysis. It could inhibit the proliferation of methicillin-resistant &lt;i>Staphylococcus aureus&lt;/i> and reduce its metabolic activity with low bacterial resistance. Further investigations revealed that the highly active compound &lt;b>4&lt;/b> could not only disrupt cell membrane integrity and induce excessive reactive oxygen species within </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-05-28T03:18:37.598Z</modification><creation>2026-05-28T03:10:57.218Z</creation></dates><accession>S-EPMC12733231</accession><cross_references><pubmed>41465266</pubmed><doi>10.3390/ijms262411836</doi></cross_references></HashMap>